Veradermics, INC S-1 registration statements

Veradermics, Incorporated has filed a Form S-1 registration statement to allow for the resale of up to 16,772,058 shares of common stock and 300,000 shares underlying pre-funded warrants by selling stockholders.

Veradermics, Inc. has filed to increase its initial public offering by approximately $56.8 million, bringing the total potential aggregate offering to over $442 million.

Veradermics, Incorporated has filed a registration statement for a follow-on offering of 3,350,000 shares of common stock or pre-funded warrants to fund commercialization and operations.